1,844 active funding opportunities
Funds development of animal and ex vivo models to improve translational neurotherapeutic discovery for neurological disorders.
Supports studies to demonstrate biological activity of neurotherapeutic agents for neurological disorders, advancing translational research to meet neurotherapeutic network criteria.
Funds multidisciplinary programs to develop new drugs and neurostimulation devices for mental and substance use disorders, encouraging academia-industry partnerships.
Supports discovery and development of new drugs and neurostimulation devices to treat mental and substance use disorders with academia-industry partnerships.
Funds preparatory studies to improve design and feasibility of cancer prevention and control clinical trials.
Funds small scale biomedical research and minimal risk clinical trials at underfunded health professional and graduate schools.
Supports planning and preparatory studies for clinical trials improving cancer prevention, screening, treatment symptom management, and survivor outcomes.
Supports HIV/AIDS research aligned with NIDDK mission and NIH HIV/AIDS priorities, clinical trial optional.
Supports renewal of existing NINDS clinical trial cooperative agreements needing more time and resources to complete trials.
Supports development of computational tools and models to analyze dynamic brain circuits and advance brain disorder treatments.
Funds established investigators to build research capacity and mentorship in aging and Alzheimer's Disease without leading independent clinical trials.
Supports NINDS intramural neurologist- and neurosurgeon-scientists transitioning to independent research and clinical faculty roles.
Supports neurologist- and neurosurgeon-scientists transitioning from NIH intramural roles to independent academic research and clinical positions.
Funds advanced pre-clinical research on nanotechnology-based cancer diagnostics and therapeutics to improve treatment effectiveness.
Supports innovative multisite clinical trials leveraging NICHD Network infrastructure focused on women, children, pregnant and lactating women, and persons with disabilities.
Supports research on novel newborn screening methods and therapies for fatal or disabling conditions, including high priority genetic disorders.
Funds pilot research on biological, behavioral, and social mechanisms contributing to HIV pathogenesis within NIDDK's mission, excluding clinical trials.
Funds innovative basic research on biological/genetic causes of cancer health disparities, including mechanistic studies and new methodologies.
Funds research on novel newborn screening methods and therapies for fatal or disabling conditions, including emerging genetic disorders.
Funds pilot projects to study understudied proteins linked to rare diseases, supporting preliminary data and tool development.
Funds research on the harmful effects and delayed impacts of acute exposure to ultra-potent synthetic opioids like fentanyl and carfentanil.
Supports foundational research proposals in basic, applied, and advanced technology development for Army overmatch in future conflicts.
Funds innovative analysis of existing data to study drug use behaviors, prevention, and health service utilization, excluding clinical trials.
Supports innovative analysis of existing data to study drug use behaviors, prevention, and health service utilization.
